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Summary 
Recent biochemical and genetic studies indicate that 
in addition to the octamer-binding proteins Oct-1 and 
Oct-2, other B cell components are required for lym- 
phoid-restricted, octamer site-mediated immunoglob- 
ulin gene promoter activity. Using a genetic screen in 
yeast, we have isolated B cell-derived cDNAs encod- 
ing Oct-binding factor 1 (OBF-1), a novel protein that 
specifically associates with Oct-1 and Oct-2o Biochem- 
ical studies demonstrate that OBF-1 has no intrinsic 
DNA-binding activity and recognizes the POU domains 
of Oct-1 and Oct-2, but not those of Oct-4 and Oct-6. 
The OBF.1 mRNA is expressed in a highly cell-specific 
manner, being most abundant in B cells and essentially 
absent in most of the other cells or tissues tested. 
Furthermore, expression of OBF-1 in HeLa cells selec- 
tively stimulates the activity of a natural immunoglobu- 
lin promoter in an octamer site-dependent manner. 
Thus, OBF-1 has all the properties expected for a B 
cell-specific transcriptional coactivator protein. 
Introduction 
The B cell-restricted expression of immunoglobulin genes 
is dependent on promoter and enhancer elements that 
are B cell-specific in their activity. The most conspicuous 
regulatory element of immunoglobulin genes is the oc- 
tamer motif (consensus sequence ATTTGCAT) that is 
present in every immunoglobulin promoter and in most 
immunoglobulin enhancers (reviewed by Staudt and Len- 
ardo, 1991). The critical role of the octamer motif for high 
level activity of immunoglobulin promoters in B lympho- 
cytes has been well documented (Falkner and Zachau, 
1984; Mason et al., 1985; Mizushima-Sugano and Roeder, 
1986; Jenuwein and Grosschedl, 1991). Deletion of this 
promoter element results in a drastic reduction of immuno- 
globulin gene expression, and a single octamer motif is 
sufficient o confer B cell specificity to a heterologous mini- 
mal promoter (Dreyfus et al., 1987; Wirth et al., 1987). 
In addition, multimerization of an octamer site creates a 
potent B cell-specific enhancer able to activate transcrip- 
tion from a remote position (Gerster et al., 1987). However, 
B cell-restricted activity of the immunoglobulin octamer 
motif must also depend on the promoter context, as this 
same element is critical for the activity of promoters and 
enhancers of many nonlymphoid-specific genes such as 
the histone H2B or the U1-U6 small nuclear RNA genes 
(LaBella et al., 1988; Murphy et al., 1989). 
Several nuclear proteins binding specifically to the oc- 
tamer site have been identified and their cDNAs cloned 
(reviewed by SchSler, 1991). All are members of the POU 
family of homeodomain proteins sharing a common bipar- 
tite DNA-binding domain that comprises an N-terminal 
POU-specific domain and a C-terminal 'homeodomain 
(Herr et al., 1988). Two octamer-binding proteins with iden- 
tical DNA binding specificities are present in B cells: one 
of them, Oct-l, is a single protein expressed ubiquitously 
(Sturm et al., 1988), whereas the second, Oct-2, comprises 
several isoforms and is largely B cell restricted (Staudt et 
al., 1986; Clerc et al., 1988; MLiller et al., 1988; Wirth et 
al., 1991). This observation led to the original proposal 
that the Oct-2 protein has a specialized function in B lym- 
phocytes with respect to immunoglobulin transcription. 
This model was further supported by the demonstration 
that overexpression of Oct-2 in non-B cells could effi- 
ciently activate octamer-containing promoters (M011er et 
al., 1988). 
However, more recent findings challenged this model. 
First, several B cell lines have been reported to express 
immunoglobulin genes at high levels and yet to contain 
only little or no detectable Oct-2 factor (Johnson et al., 
1990). Second, in vitro transcription experiments howed 
that purified Oct-1 or Oct-2 proteins have a similar intrin- 
sic capacity to stimulate an immunoglobulin promoter 
(Scheidereit et al., 1987; LeBowitz et al., 1988; Pierani et 
al., 1990; Luo et al., 1992). Third, immunoglobulin genes 
are rearranged and transcribed normally, and early B cell 
development appears unaffected in oct-2-deficient mice 
generated by gene targeting, indicating that Oct-2 is dis- 
pensable in the first, antigen-independent phase of B cell 
differentiation (Corcoran et al., 1993). These observations, 
together with the finding that immunoglobulin promoters 
are much more active in unfractionated B cell extracts 
than in HeLa extracts supplemented with Oct-1 or Oct-2 
(Pierani et al., 1990; Luo et al., 1992), suggested that other 
B cell-specific components are responsible for lymphoid- 
restricted transcription of immunoglobulin promoters. In- 
deed, a protein fraction has been recently isolated from 
a B cell nuclear extract that specifically stimulates tran- 
scription from an immunoglobulin promoter in conjunction 
with purified Oct-1 or Oct-2. The factor responsible for this 
activity has been called OCA-B and has been proposed 
to function as a B cell-specific coactivator for octamer 
proteins (Luo et al., 1992). 
We used a transcription-based selection for protein-pro- 
tein interactions in yeast to identify proteins that can inter- 
act with Oct-l. Here we report the isolation of Oct protein- 
binding factor 1 (OBF-1), a B cell-restricted protein that 
specifically interacts with both Oct-1 and Oct-2, but not 
with the octamer motif. We also present evidence for a 
direct role of OBF-1 as a coactivator for octamer-binding 
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Figure 1. Strategyforlsolating ProteinsthroughTheirlnteractionwith 
Oct-1 
A direct interaction between Oct-l, which is transcriptionally inactive 
in yeast, and a cDNA-encoded protein fused to the VP16 activation 
domain would induce HIS3 transcription and thus allow the ceils to 
grow in the presence of AT, a competitive inhibitor of the HIS3 gene 
product. The Oct-1 protein and the VP16-cDNA librarywere expressed 
from single copy plasmids marked with the URA3 and TRP1 genes, 
respectively. Expression of the VP16 hybrid proteins was placed under 
control of the galactose-inducible GALI,IO regulatory sequences 
(UAS~). 
transcription factors in B cell-restricted expression of im- 
munoglobulin genes. 
Results 
Isolation of OBF-1, a Protein That Interacts 
with Oct-1 and Oct-2 in Yeast 
To isolate cDNAs encoding proteins that associate with 
Oct-l, we used a yeast genetic selection related to two- 
hybrid protein interaction screening (Fields and Song, 
1989). We first constructed a parental yeast strain carrying 
as a selectable marker gene an integrated copy of a HIS3 
allele with six octamer motifs upstream of the TATA ele- 
ment (Figure 1). The cells also contain a centromeric plas- 
mid marked with the URA3 gene that directs constitutive 
expression of Oct-l. As Oct-1 cannot activate transcription 
in yeast (see below), the resulting tester strain transcribes 
the HIS3 gene at basal levels and thus grows on medium 
lacking histidine but not in the presence of aminotriazole 
(AT), a competitive inhibitor of the HIS3 gene product. The 
strain was then transformed with a library of randomly 
primed cDNA fragments prepared with mRNA from the B 
cell line Namalwa, fused C.terminal to the transcriptional 
activation domain of the herpes simplex virus (HSV) VP16 
protein, and expressed from a centromeric TRP1 plasmid 
under control of a galactose-inducible promoter (Figure 
1). The library (2 x 106 primary transformants) was first 
amplified in glucose medium lacking uracil and tryptophan 
to maintain selection for both plasmids, before being 
plated onto medium containing galactose, which induces 
expression of the fusion library, and 10 mM AT. Cells that 
grow under these selective conditions must express VP16 
Oct-1 + + + 
Oct-2 + + + 
VP16.OBF-1 + + + + + 
-His 
AT 
Hw H m 
Figure 2. OBF-1 Interacts with Both Oct-1 and Oct-2 in Yeast 
Yeast strains containing wild-type (Hw) or mutated (Hm) IgH promoter- 
derived octamer sites upstream of the HIS3 TATA element and ex- 
pressing the indicated proteins from plasmid DNAs were plated on 
medium lacking histidine (minus His) or containing 40 mM AT. Only 
cells expressing induced levels of the HIS3 gene can grow in the pres- 
ence of AT. 
hybrid proteins that stimulate HIS3 transcription either by 
interacting directly with HIS3 regulatory sequences or by 
being recruited to the HIS3 promoter through their interac- 
tion with DNA-bound Oct-l. Among the 55 AT-resistant 
colonies that were further considered, four lost their ability 
to grow on AT when their Oct-1 plasmids were removed, 
indicating that in these cells transactivation resulted from 
the formation of a complex between Oct-1 and the protein 
fused to VP16. Partial sequence analysis of the library 
plasmids recovered from these colonies revealed that they 
contained three independent cDNA inserts derived from 
the same cellular mRNA. On the basis of its ability to inter- 
act specifically with Oct-l, we named the protein encoded 
by this mRNA OBF-1, for Oct protein-binding factor 1. 
To confirm more directly that OBF-1 requires Oct-1 for 
recruitment to the octamer site and to assess its ability to 
interact with the other octamer-binding protein present in 
B lymphocytes, we tested the activity of an octamer- 
dependent HIS3 gene in cells expressing VP16-tagged 
OBF-1 either alone or in combination with Oct-1 or Oct-2. 
Figure 2 shows that yeast cells expressing any of these 
proteins individually were unable to activate the HIS3 gene 
and, therefore, failed to grow in the presence of AT. How- 
ever, when either Oct-1 or Oct-2 was coexpressed with 
VP16-OBF-1 in the reporter strain, transactivation of the 
HIS3 gene occurred. Moreover, expression was com- 
pletely dependent on the presence of wild-type octamer 
sequences in the HIS3 promoter. We concluded from these 
experiments that OBF-1 fused to VP16 has no indepen- 
dent transcriptional ctivity and requires promoter-bound 
Oct-1 or Oct-2 factors to stimulate octamer site-depen- 
dent transcription in yeast. 
OBF-1 Is a Novel Protein Expressed Only in B Cells 
The nucleotide sequence of the cDNA insert with the lon- 
gest 5' extension was determined, and the deduced amino 
acid sequence is presented in Figure 3. OBF-1 is a novel 
protein of 256 amino acids with a predicted molecular 
mass of 27.4 kDa and an apparent molecular mass of 
about 35 kDa on SDS-polyacrylamide gels after in vitro 
translation (data not shown). This protein shows no obvi- 
ous similarities to any known protein and, except for its 
richness in proline residues that are scattered throughout 
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Figure 3. OBF-1 Is a Novel Protein Rich inProline Residues 
Deduced amino acid sequence derived from the OBF-1 cDNA with the 
longest 5' extension. The first methionine r sidue is found at base pair 
97 of the cDNA. Primer extension analyses indicated that the OBF-1 
mRNA extends only approximately 10 nt upstream of this cDNA (data 
not shown). Proline residues are circled. 
the entire sequence (41 residues or 16%), does not display 
any particular structural features. 
The pattern of OBF-1 expression was determined in vari- 
ous organs and cell lines by Northern blot analyses. A 
major RNA species of about 3.2 kb was detected in splee n, 
in peripheral blood lymphocytes, and, very weakly, in thy- 
mus and small intestine (Figure 4A). Prostate, testis, 
ovary, and colon were negative (Figure 4A), as well as 
brain, skeletal muscle, placenta, lung, kidney, and pan- 
creas (data not shown). OBF-1 is strongly expressed in all 
human B cell lines tested (Figure 4B, lanes 3-5), and a 
similarly sized RNA was detected in two mouse B cell lines 
(lanes 1-2). By contrast, no OBF-1 mRNA was found in 
several non-B cells such as HeLa, 293T, MCF7, and K562 
or in the T cell line HUT78. Taken together, these data 
indicate that the OBF-1 gene is expressed in a highly B 
lymphocyte-specific manner. 
OBF-1 Interacts Specifically with the POU Domain 
of Oct-1 and Oct-2 to Form a Ternary Complex 
on DNA 
The experiments carried out in yeast provide genetic evi- 
dence for a recruitment of OBF-1 to the octamer site 
through its physical association with Oct-1 or Oct-2. To 
confirm this more directly, we performed electrophoretic 
mobility shift assays (EMSAs) using a radiolabeled oligo- 
nucleotide bearing a single octamer motif and nuclear ex- 
tracts from 293T cells transiently transfected with vectors 
encoding a hemagglutinin (HA) epitope-tagged version of 
OBF-1, Oct-2, or both. Figure 5 shows that in addition to 
the single complex formed with extracts from control- 
transfected cells and owing to binding of endogenous 
Oct-1 to the DNA (lanes 2, 4, and 5), a second, slower- 
migrating complex was observed with extracts from cells 
expressing OBF-1 (lanes 6, 8, and 9). Two additional com- 
plexes were formed in the presence of Oct-2. The faster- 
migrating complex resulted from independent binding of 
Oct-2 to the octamer motif (Figure 5, lanes 10, 12, and 
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Figure 4. 8 Cell-Restricted Expression of the OBF-1 Gene 
(A) Northern blot analysis of poly(A) ÷ RNA isolated from the indicated 
human tissues. The filter was hybridized to the 2 kbcDNA insert pres- 
ent in clone 9 (see Experimental Procedures). The RNA size markers 
are given in kilobases. Abbreviation: pbl, peripheral blood lymphocyte. 
(B) Northern blot analysis of total RNA purified from the indicated cell 
lines. Two murine cell lines have been used: $194, a plasmacytoma, 
and MPC11, a myeloma. The other cells are from human origin: Nalm6 
is a pre-B cell line, BJA-B is a lymphoblastoid l ne, and Namalwa is 
a Burkitt lymphoma. HeLa is a cervix carcinoma, 293T is a transformed 
primary embryonic kidney line, MCF7 is a breast adenocarcinoma, 
K562 is a chronic myeloid leukemia, and HUT78 is a T cell ymphoma. 
The positions of 28S and 18S ribosomal RNAs are indicated. As a 
control for RNA loading and integrity, the same filters were r hybrid- 
ized to an actin probe. 
13), and the upper complex was only observed with ex- 
tracts from cells expressing both Oct-2 and OBF-1 (lanes 
14, 16, and 17). Addition of the 12CA5 monoclonal anti- 
body that recognizes the HA epitope present on OBF-1 
specifically affected migration of the OBF-l-dependent 
complexes (Figure 5, lanes 8 and 16), and this effect was 
abolished by inclusion of the HA peptide to the antibody- 
supplemented reactions (lanes 9 and 17). These data dem- 
onstrate that OBF-1 forms a ternary complex with Oct-1 
or Oct-2 on the cognate site. 
The POU domain is the only region of extensive similar- 
ity between Oct-1 and Oct-2 (Herr et al., 1988) and is there- 
fore likely to provide the surface for interaction with OBF-1. 
This possibility was directly examined by testing the ability 
of in vitro translated O8F-1 and POU domains of various 
octamer factors to form a complex on DNA. Figure 6A 
shows that the POU domains of Oct-1 and Oct-2 were 
indeed sufficient for interaction with OBF-1, whereas no 
complex was formed between OBF-1 and the same do- 
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Figure 5. OBF-1 Associates with Oct-1 and Oct-2 on Promoter DNA 
EMSA performed with nuclear extracts from 293T cells transiently 
transfected with the empty expression vector pEVRF0 (lanes 2-5) 
or with vectors expressing HA epitope-tagged OBF-1 (HA-OBF-1) or 
Oct-2a (one of the major Oct-2 isoforms) as indicated (lanes 6-17). 
Equal amounts of nuclear extracts prepared 2 days after transfection 
were incubated with an octamer site-containing DNA probe. As indi- 
cated at the top left, some reactions contained in addition a 200-fold 
excess of cold competitor DNA (octa) or the anti-HA 12CA5 monoclonal 
antibody (a-HA), with or without the HA peptide (HA). The protein- 
DNA complexes were resolved on a 40/0 polyacrylamide nondenatur- 
ing gel. 
mains of the more divergent POU proteins Oct-4/Oct-3 
(SchSler et al., 1990; Okamoto et al., 1990) and Oct-6/ 
SCIP (Suzuki et al., 1990; Monuki et al., 1990). Impor- 
tantly, no prote in-DNA complex was observed after incu- 
bation of the DNA probe with OBF-1 alone, indicating that 
this protein is unable to interact stably with the octamer 
motif on its own. When C-terminally truncated versions of 
OBF-1 were used with the POU domain of Oct- l ,  com- 
plexes of increasing mobility were observed (Figure 6B). 
These experiments provide further evidence that OBF-1 
is present in a ternary complex, and they localize the do- 
main mediating interaction with octamer factors within the 
first 120 amino acids of OBF-1. 
Although OBF-1 exhibits no independent DNA-binding 
activity, its association with octamer factors may stabilize 
their interaction with the octarner motif. To address this 
issue, we compared the rates of dissociation of Oct-1 and 
OBF-1-Oct-1 from the octamer motif. As shown in Figure 
6C, the dissociation rate of Oct-1 from its binding site was 
not influenced by the presence of OBF-1 in the complex. 
Identical results were obtained when Oct-2 was used in 
place of Oct- l .  OBF-1 was also found to have no effect 
on the kinetics of Oct-1 and Oct-2 binding to their cognate 
sequence (data not shown). Taken together, these experi- 
ments demonstrate that OBF-1 has no intrinsic DNA- 
binding activity and that it interacts indirectly with the oc- 
tamer motif through its specific association with the POU 
domains of Oct-1 and Oct-2. 
A 
POU 
domain 
OBF-1 
OBF-1/POU/__~ 
DNA 
none POU-1POU~ POU4 POU~ 
POU/DNA -~-  
DNA 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
B 
POU-11DNA 
DNA "~ 
+ OBF-1 C 
Time 
(rain) 
OBF-1/Oct-1 
/DNA ~ 
Oct-1/DNA 
0 5 10 2040 60' 
Oct-1/DNA --~ 
1 23456 1 2 3 4 5 6 7 
Figure 6. Specific Interaction f OBF-1 with the POU Domain of Oct-1 
and Oct-2 
(A) EMSA performed with constant amounts of reticulocyte lysates 
programmed with plasmid DNAs encoding the POU domains of Oct-1 
(lanes 5-7), Oct-2 (lanes 8-10), Oct-4 (lanes 11-13), and Oct-6 (lanes 
14-16) combined with increasing amounts of OBF-I' lysate. The total 
amount of lysate was equalized in each reaction by the addition of 
unprogrammed lysate. The low amounts of Oct-1 protein present in 
the reticulocyte lysate forms a faint complex with the DNA probe, part 
of which gives rise to a lower mobility complex in the presence of 
OBF-1 (small arrows). 
(B) EMSA performed with the POU domain of Oct-1 in combination 
with either full-length OBF-1 (lane 3) or with derivatives truncated at 
amino acid 193 (lane 4), amino acid 139 (lane 5), or amino acid 119 
(lane 6). 
(C) Dissociation rates of Oct-1 (lower panel) and OBF-1-Oct-1 (upper 
panel) from the octamer site. Binding reactions were incubated for 20 
rain at ambient emperature before the addition of a 200-fold excess 
of specific competitor DNA. Aliquots of the reactions were loaded onto 
a running gel at the indicated timepoints (lanes 2-7). 
Transient Expression of OBF-1 in Non-B Cells 
Stimulates the Activity of an Immunoglobulin 
Light Chain Promoter 
The strong correlation between the expression pattern of 
OBF-1 with that of immunoglobul in genes suggests a role 
for this protein in B cell-restricted activity of immunoglobu- 
lin promoters. To address this issue, we assessed whether 
expression of OBF-1 would be sufficient to stimulate tran- 
scription from an immunoglobul in promoter in non-B  cells. 
As a target gene, we used a hybrid plasmid containing 
the coding sequences of the luciferase gene under the 
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Figure 7. Selective Stimulation of an Octamer-Dependent Immuno- 
globulin Promoter by OBF-1 in HeLa Cells 
(A) Activities of the reporter plasmids pKappaLucE (wild-type K pro- 
moter; lanes 1-4), pKappaO-LucE (mutated octamer site; lanes 5-7), 
or pKappaSP1LucE (SP1 site replacing the octamer element; lanes 
8-10) upon cotransfection with an empty expression vector (lanes 1, 
5, and 8), the OBF-1 expression vector (lanes 2, 4, 6, and 9), or the 
Oct-2a expression vector (lanes 3, 4, 7, and 10) in HeLa cells. Cell 
extracts were prepared 2days after transfection, and equivalent pro- 
tein amounts were used for the luciferase assays. Promoter activities 
are indicated in relative light units (RLU). 
(B) Activities of the reporter plasmids pKappaLucE and pH2BLucE 
upon cotransfection with an empty expression vector (lanes 1 and 3) 
or the OBF-1 expression vector (lanes 2 and 4) in HeLa cells. The 
relative fold stimulation by OBF-1 is indicated. 
control of a 200 bp immunoglobulin 1< light chain gene 
promoter fragment (Junker et al., 1990). This promoter 
contains a single octamer motif upstream of the TATA 
element and supports low levels of transcription after tran- 
sient transfection into HeLa cells that only express the 
ubiquitous Oct-1 factor (Figure 7A, lane 1). This basal ac- 
tivity was strongly stimulated upon cotransfection of the 
OBF-1 expression vector (Figure 7A, lane 2) to a level of 
transcription significantly higher than that observed when 
a vector expressing Oct-2 was used (lane 3). Interestingly, 
cotransfection of OBF-1 and Oct-2 led to even higher im- 
munoglobulin promoter activity (Figure 7A, lane 4), indicat- 
ing that both octamer-binding proteins that form a ternary 
complex with OBF-1 on DNA in vitro can mediate OBF-1 
transactivation i  vivo. Activated transcription was strictly 
dependent on the presence of an intact octamer motif, as 
mutations in this element (Figure 7A, lanes 5-7) render 
the promoter nonresponsive to OBF-I. Furthermore, re- 
placement of the octamer motif within the K promoter by 
an SPl-binding site creates a chimeric promoter that is 
active, but not influenced by OBF-1 (Figure 7A, lanes 
8-10). 
In addition, we have tested the effect of OBF-1 on tran- 
scription from the histone H2B promoter, whose activity 
is also dependent upon an intact octamer element (Pierani 
et al., 1990). Figure 7B shows that a 325 bp fragment 
encompassing the natural H2B promoter supports higher 
levels of transcription than the immunoglobulin K promoter 
after transient transfection into HeLa cells (lanes 1 and 
3). This is expected, as the H2B gene is ubiquitously ex- 
pressed. Cotransfection of OBF-1 stimulates H2B pro- 
moter activity only about 2-fold, which contrasts with the 
7- to 10-fold effect of OBF-1 on transcription from the im- 
munoglobulin promoter (Figure 7B, lanes 2 and 4). Hence, 
OBF-1 exhibits a marked promoter preference. The high 
basal level transcription of the H2B promoter construct is 
explained by the presence of an SV40 enhancer down- 
stream of the luciferase gene. The same enhancer is also 
present in the immunoglobulin promoter constructs, 
where it is required to reach detectable levels of transcrip- 
tion in non-B cells. Although removal of the SV40 en- 
hancer reduces H2B promoter activity roughly to basal 
immunoglobulin promoter levels, it does not increase its 
responsiveness to OBF-1 (data not shown). The weak but 
reproducible ffect of OBF-t on the histone H2B promoter 
suggests that B cell components uch as OBF-1 may con- 
tribute to the activity of ubiquitous promoters in B cells. 
Discussion 
The crucial role of the octamer motif for high level activity 
of immunoglobulin promoters in B cells has been well doc- 
umented. As mentioned in the Introduction, recent data 
indicate that the two octamer-binding proteins present in 
B lymphocytes require additional B cell components to 
mediate cell-restricted immunoglobulin promoter activity 
(Pierani et al., 1990; Luo et al., 1992). Here we describe 
the molecular cloning and initial characterization of a pro- 
tein that has all the properties expected for a cell-specific 
and transcriptio n factor-specific coactivator. We desig- 
nated this protein OBF-I. OBF-1 is a novel protein ex- 
pressed only in B cells that has no intrinsic DNA-binding 
activity and that interacts pecifically with Oct-1 and Oct-2 
on promoter DNA. Furthermore, expression of OBF-1 in 
fibroblast cells that only contain Oct-1 is sufficient o acti- 
vate efficiently an immunoglobulin promoter specifically 
through the octamer motif. Recently, Luo et al. (1992) de- 
scribed a protein fraction isolated from a B cell extract 
that activates transcription of an artificial immunoglobulin 
promoter construct by potentiating the activity of purified 
Oct-1 or Oct-2 but not of other activators. The factor re- 
sponsible for this activity, called OCA-B, could not be puri- 
fied from HeLa nuclear extracts and did not exhibit inde- 
pendent ranscription activation or DNA-binding activities, 
much like OBF-I. However, although OCA-B did function 
with both Oct-1 and Oct-2, a physical association could 
only be demonstrated with Oct-l, unlike what we have 
shown for OBF-I. In addition, OCA-B had no effect on 
activity of the histone H2B promoter, whereas OBF-1 
weakly but reproducibly stimulates the H2B promoter in 
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transient ransfection experiments. Therefore, it is at pres- 
ent difficult o estimate to what extent OBF-1 and OCA-B 
are related proteins. 
Potential Role of OBF-1 for B Cell-Restricted 
Immunoglobulin Gene Activity 
We have found that expression of the OBF-1 gene is highly 
B lymphocyte specific: spleen, peripheral blood lympho- 
cytes, and thymus were the only organs in which OBF-1 
mRNA was found, albeit at quite different levels (Figure 
4A). In addition, OBF-1 expression was also detected 
weakly in the small intestine, an organ that contains some 
B cells in the form of Peyer's patches. Of the various cell 
lines tested, only B cells were positive. The finding that 
OBF-1 is expressed in the pre-B cell line Nalm6 is of partic- 
ular interest, as these cells had been shown to contain 
extremely low levels of Oct-2 protein, yet transcribe high 
levels of immunoglobulin mRNA (Johnson et al., 1990). 
Thus, OBF-1 is differentially expressed with a pattern that 
coincides with that of immunoglobulin genes. 
Expression of OBF-1 in HeLa cells efficiently activates 
a cotransfected immunoglobulin K light chain promoter 
construct, while it has only a modest effect on histone H2B 
promoter activity. For this effect, integrity of the octamer 
motif is essential because mutation of the octamer site or 
its replacement by an SPl-binding site renders the immu- 
noglobulin promoter nonresponsive to OBF-1. In these 
cells, OBF-1 necessarily acts in conjunction with the en- 
dogenous Oct-1 factor, which is the only octamer-binding 
protein present in fibroblasts. By contrast, B cells also 
express the Oct-2 protein in addition to Oct-l, and there- 
fore OBF-1 might activate immunoglobulin transcription 
in association with Oct-2 as well. Since no mammalian 
cell line is available lacking Oct-l, we could not directly 
test that possibility. However, cotransfection experiments 
with Oct-2 and OBF-1 in HeLa cells indicated that OBF-1 
is able to stimulate immunoglobulin transcription in con- 
junction with Oct-2 alsb (Figure 7A). 
In addition to being present in all immunoglobulin pro- 
moters, the octamer motif is also found in most immuno- 
globulin enhancers, where it contributes to their B cell- 
restricted activity. Furthermore, multimerized octamer 
sites behave as B cell-specific enhancers, capable of 
stimulating transcription from remote positions (Gerster 
et al., 1987). The Oct-2 protein is necessary for enhancer 
function (Annweiler et al., 1992; Pfisterer et al., 1994) but 
not sufficient (Mfiller-lmmergluck et al., 1990): an addi- 
tional B cell-restricted activity is also required (Annweiler 
et al., 1992). Whether OBF-1 encodes this stimulating ac- 
tivity is not yet established, but genetic evidences suggest 
that activity of promoter and enhancer octamer sites re- 
quires distinct cofactors (Pfisterer et al., 1994; Feldhaus 
et al., 1993). However that may be, the very highly B lym- 
phocyte-specific pattern of OBF-1 expression together 
with its selective stimulatory effect on immunoglobulin pro- 
moters strongly indicates that OBF-1 is a critical determi- 
nant of immunoglobulin transcription in lymphoid cells. 
OBF-1 Is a Novel Protein Rich in Proline Residues 
OBF-1 is a novel protein of 256 amino acids that does 
not contain any obvious structural or functional motifs. 
In particular, this protein does not show any similarity to 
known DNA-binding domains and is devoid of regions rich 
in basic amino acids, consistent with its inability to interact 
with DNA on its own. OBF-1 is rich in proline residues 
(16%) and, to a lesser extent, in serine and threonine resi- 
dues scattered throughout he entire protein. Proline-rich 
activation domains have been previously reported for sev- 
eral transcription factors, such as NF-1/CTF1 (Mermod et 
al., 1989) or AP-2 (Williams et al., 1988); thus, it is possible 
that some parts of OBF-1 serve a similar function. Interest- 
ingly, the central region of OBF-1 (positions 86-151) 
shows a weak homology (24% identity or 38% similarity 
by FASTA comparison) to amino acids 570-639 of CCG 1, 
a human protein initially implicated in cell cycle regulation 
(Sekiguchi et al., 1991) that has been recently shown to 
correspond to the 250 kDa TATA-binding protein-associ- 
ated factor TAF250 (Ruppert et al., 1993; Hisatake et al., 
1993). This homology falls in a region of TAF250/CCG1 
to which no function has been ascribed so far (Hisatake 
et al., 1993) and therefore may define a novel domain in 
this protein. 
OBF-1, a Novel Modulator for Octamer Factors 
Octamer-binding proteins constitute an interesting family 
of transcription factors in that they appear critically to de- 
pend for their function on additional proteins. For example, 
Oct-1 and another member of the POU family of transcrip- 
tion factors, Pit-l, form a heteromeric omplex in the ab- 
sence of DNA and function synergistically in transactivat- 
ing the expression of a pituitary-specific gene through their 
codependent binding to the Pit-1 response element (Voss 
et al., 1991). In a similar way, activation of the interleukin-2 
promoter requires a complex between Oct-1 and AP-1 or 
OAP 4° (Pfeuffer et al., 1994; UIIman et al., 1991); OAP 4° 
is a heterodimer between two members of the Jun family 
that reduces the dissociation rate of Oct-1 from its cognate 
site by interacting with adjacent DNA sequences (UIIman 
et al., 1991). In these two cases, Oct-1 interacts with pro- 
teins that also function as independent ranscription fac- 
tors. However, other cases have been reported in which 
the activity of octamer factors is potentiated by protein 
components, such as OBF-1, that must function as coacti- 
vators as they exhibit no independent DNA-binding and 
transcriptional activities. For example, Oct-1 activates 
transcription of HSV immediate-early genes through its 
binding to the TAATGARAT motif only in association with 
the viral protein VP16 (O'Hare and Goding, 1988; Gerster 
and Roeder, 1988; Kristie et al., 1989) and a host cell 
factor, HCF (Wilson et al., 1993). Another example is illus- 
trated by Oct-4, which requires adenovirus E1A protein 
for activating transcription through distal octamer sites in 
a way that correlates with formation of a complex between 
the two proteins on DNA (Sch~ler et al., 1991). An activity 
functionally analogous to E1A has been identified in em- 
bryocarcinoma cells and proposed to represent a cellular 
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coactivator specific for Oct-4 (SchSler et al., 1991). Here 
we present evidence that high level activity of immuno- 
globulin promoters in B cells requires the recruitment of 
OBF-1 to the promoter through its association with Oct-l, 
Oct-2, or both. 
Interestingly, E1A, VP16, and OBF-1 all interact with 
octamer factors via their POU domain. Yet the three pro- 
teins exhibit distinct specificities: whereas E 1A recognizes 
Oct-4, VP16 binds to only Oct-l, and OBF-1 interacts 
equally with both Oct-1 and Oct-2, but not with Oct-4 and 
Oct-6 (Figure 6A). Oct-1 and Oct-2 are closely related 
members of the same class of POU proteins, whereas 
Oct-4 and Oct-6 are more divergent and belong to different 
classes. It is therefore highly unlikely that OBF-1 is the 
embryocarcinoma cell-specific E1A-like activity, although 
one cannot exclude the possibility that the two proteins 
are related. Oct-1 and Oct-2 proteins share highly related 
POU domains that only differ by one residue in the 75 
amino acid long POU-specific domain and by seven resi- 
dues in the 60 amino acid long POU homeodomain. A 
glutamic acid at position 22 in the first helix of the Oct-1 
homeodomain was shown to be the single critical residue 
for VP16 to discriminate between Oct-1 and Oct-2 (Lai et 
al., 1992; Pomerantz et al., 1992). The observation that 
OBF-1 associates with both Oct-1 and Oct-2 may suggest 
that, unlike VP16, this protein recognizes the POU-specific 
domain rather than the POU homeodomain, and it will 
be interesting to define further which part of the octamer 
proteins is mediating OBF-1 recognition. 
Mechanism of Transcription Activation by OBF-1 
By which mechanism does OBF-1 potentiate the activity 
of octamer-binding transcription factors in B cells? One 
possibility is that this protein functions by modifying cata- 
lytically octamer factors, thereby enhancing their activa- 
tion potential. Alternatively, OBF-1 could facilitate nuclear 
translocation of these factors in B cells. However, it is more 
likely that OBF-1 exerts its effect on the immunoglobulin 
promoter itself. First, the protein is clearly able to translo- 
care into the nucleus, as it can be found in association 
with Oct-1 or Oct-2 in nuclear extracts from transfected 
cells. Second, fusion of the potent VP16 acidic activation 
domain to OBF-1 results in a chimeric protein that medi- 
ates significantly higher immunoglobulin promoter activity 
in cotransfection assays (data not shown). Numerous ex- 
periments have demonstrated that the VP16 activation do- 
main stimulates RNA polymerase II transcription only 
when tethered to a promoter through its fusion to a heterol- 
ogous DNA-binding domain or through interaction with a 
promoter-bound protein. The same situation must there- 
fore also apply in the case of the VP16-OBF-1 hybrid pro- 
tein, thus implying the presence of OBF-1 on the immuno- 
globulin promoter. As the OBF-1 protein does not interact 
With DNA on its own, it must be recruited to the immuno- 
globulin promoter through association with DNA-bound 
octamer factors. 
Kinetic experiments indicated that OBF-1 has no effect 
on the association or dissociation rates of octamer proteins 
binding to the octamer motif (Figure 6C). Thus, it does 
not appear to increase the activity of octamer factors by 
stabilizing their interaction with DNA. OBF-1 must there- 
fore function in a coactivator or adaptor-like fashion by 
creating a bridge connecting octamer site-bound tran- 
scription factors to some component of the basal machin- 
ery. In that respect, it will be recalled that OBF-1 has some 
of the features of proline-rich activation domains such as 
the one found in transcription factor CTF1 (Mermod et al., 
1989), which has recently been reported to contact TFIIB 
directly (Kim and Roeder, 1994). Coactivators constitute 
a class of eukaryotic factors operationally defined as pro- 
teins that are required for transcription factor function but 
that have no independent transcriptional ctivities. Coacti- 
vators include the TAFs present in the TFIID complex 
(Tanese and Tjian, 1993). OBF-1 may therefore represent 
a cell type-specific TAF, and it will be interesting to test 
whether it can be found in a TFIID subcomplex. 
Until recently, the prevailing view was that cell type- 
specific regulation of gene transcription is mediated by 
sequence-specific DNA-binding proteins whose expres- 
sion or activity is restricted to the corresponding cells. 
Immunoglobulin genes may represent an example in 
which such a strategy does not strictly apply, as their cell- 
restricted expression is likely to require the B cell-specific 
coactivator.OBF-1 for function of octamer factors on the 
immunoglobulin promoters. One may speculate that a sim- 
ilar mechanism could specify restricted expression of 
other cell type-specific genes, such as those for which 
no difference in promoter occupancy can be observed. 
Experimental Procedures 
All recombinant DNA work was done according to standard procedures 
(Ausubel et al., 1990), and details of the plasmid constructions and 
methods used are available upon request. 
Yeast Strains and Expression Vectors 
The yeast strains are derivatives ofKY320 (relevant genotype ura3-52 
trpl-D1 his3-200 GAL÷; Chen and Struhl, 1988) into which the HIS3 
locus was replaced by the relevant HIS3 alleles. These alleles were 
constructed by inserting restriction fragments or synthetic oligonucleo- 
tides containing wild-type or mutated octamer motifs at the unique 
EcoRI site of YIp55-Sc3760 (Harbury and Struhl, 1989). The Oct-1 and 
Oct-2 proteins were expressed constitutively from pRS316 by inserting 
the protein-coding regions between regulatory sequences derived 
from the yeast TBP gene (Cormack et ai., 1991). Both proteins contain 
an N-terminal SV40 nuclear localization signal. The library of hybrid 
proteins between anuclear-localized VP16 activation domain and ran- 
dom cDNA fragments was expressed from pRS314 under the control 
of a GAL-HIS3 hybrid promoter that had been amplified by PCR from 
plasmid 3801 (Singer et al., 1990). The vector also contains 3' termina- 
tion signals from the yeast TBP gene (Cormack et al., 1991). A cDNA 
cloning cassette consisting of a stuffer fragment flanked by two non- 
self-complementary Sillsites is present at the 3' end of the VP 16 coding 
region. 
Construction of an Activation Domain-Tagged cDNA Library 
Derived from B Cell mRNA 
Total RNA was isolated from the human B lymphoid cell line Namalwa 
(ATCC CRL 1432) by lysing the cells with guanidium thiocyanate and 
purification of the RNA over CsTFA gradients, mRNA was purified 
by two rounds of chromatography onoligo(dT) columns, cDNA was 
synthesized using the SuperScript Choice System from Life Technol- 
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ogies. First-strand synthesis was performed using 5 p.g of poly(A) ÷ 
RNA and was primed with 1 p.g of oligo(dT) and 50 ng of random 
hexamers. After second-strand synthesis, small cDNAs were elimi- 
nated by passing over a Sepharose 4CLB column, and the eluate was 
ligated to Sill adaptors. Adaptor-ligated cDNA was size fractionated 
by passing over a Sephacryl column, and the fractions were EtOH 
precipitated individually. The library vector was prepared by digestion 
with Sfil and purification over sucrose gradients in the presence of 
EtBr. cDNA-vector ligation reactions were set up with 50 ng of vector 
and varying amounts of size-fractionated cDNA. Aliquots were used 
for electroporation of DH10B bacteria. For amplification, the products 
of several electroporations were pooled (107 individual transformants) 
and plated onto LB-agar plates containing 100 I~g/ml ampicillin at a 
density of 50,000 cfu per 132 mm plate. After growth at 37°C, the 
colonies were collected and pooled. An aliquot was frozen for future 
reamplification, and the rest was used for plasmid DNA preparation. 
Screening of VP16-cDNA Fusion Library 
Screening of the cDNA library was done in a yeast strain carrying a 
H/S3 allele with six octamer sites upstream of the TATA element and 
expressing Oct-1 from a centromedc plasmid, The fusion library was 
introduced into the reporter strain according to the method of Schiestl 
and Gietz (1989), except that human poly(A)- RNA was used as carrier 
in place of salmon sperm DNA. An estimated 2 x 106 double trans- 
formants were grown for 16 hr at 30°C in glucose-selective medium, 
at which time the culture consisted of approximately 25% Trp*/Ura ÷ 
cells. After centrifugation, the cells were resuspended in galactose 
medium and incubated for 5 hr at 30°C to induce expression of the 
hybrid protein library. Transformants v~ere then plated on galactose 
synthetic medium lacking histidine and containing 10 mM AT; 55 AT- 
resistant colonies were selected for subsequent analyses. They were 
grown on synthetic medium lacking tryptophan but containing uracil 
before being plated on medium containing 5-fluoroorotic acid to select 
against cells expressing Oct-1 from the UFIA3 plasmid. The resulting 
Ura-/Trp ÷ segregants were then tested for growth on AT-containing 
medium. The library plasmids were recovered from the transformants 
that lost their ability to grow on AT when their Oct-1 plasmid was 
removed according to the method of Robzyk and Kassir (1992). The 
ability of OBF-1 to induce HIS3 transcription in conjunction with Oct-1 
and Oct-2 was determined by introducing the corresponding plasmids 
into yeast strains carrying HIS3 alleles bearing wild-type (Hw) or mu- 
tated (H,,) immunoglobulin heavy chain promoter-derived octamer- 
binding sites. Phenotypic analysis of the Ura*/Trp ÷ transformants was 
carried out by spotting approximately 104 cells onto minimal media 
lacking histidine or containing 40 mM AT. 
DNA Sequencing 
The DNA sequence of the OBF-1 cDNA clone with the longest 5'exten- 
sion (pRS314/UNVP16/clone 9) has been determined by the chain 
termination method. 
RNA and DNA Analyses 
Northern blot analysis was done by running 15 ~g of total RNA or 1 
lig of poly(A) ÷ RNA from various cell lines on formaldehyde-agarose 
gels as described (Ausubel et al., 1990). The RNA was blotted onto 
GeneScreen membranes that were UV cross-linked. In the case of 
the organ RNAs, a commercial blot (Clontech) was used. The filters 
were hybridized at 44°C in 50% formamide, 5 x SSC, 5 x Denhardt's 
solution, 0.05% NaPPi, 1% SDS, 0.1 mg/ml herring sperm DNA, and 
2 x 106 cpm/ml of the 32P-labeled OBF-1 fragment (2 kb of Sill insert 
present in clone 9). After hybridization, the filters were washed in 1 x 
SSC, 0.1o/0 SDS at 50°C and in 0.5x SSC, 0.1O/o SDS at 50°C. 
Nuclear Extracts, In Vitro Translations, and EMSAs 
Nuclear extracts from transfected mammalian cells were done as de- 
scribed previously (MOller-lmmergluck et al., 1990). For in vitro transla- 
tions, TNT reticulocyte lysates (Promega) were used following the in- 
structions of the manufacturer. All plasmids used for in vitro translation 
are based on pBGO or pBGO-ATG, two Bluescript derivatives that 
contain rabbit ~-globin leader sequences downstream of the phage T3 
promoter (T. Brabletz and P. M., unpublished ata), pBGO-ATG-OBF-1 
contains the OBF-1 clone 9 cDNA. pBGO-Octl contains the Oct-1 
cDNA and pBGO-Oct2 the Oct-2a cDNA. The POU domains present in 
pBGO-ATG-POU1, pBGO-ATG-POU2, pBGO-ATG-POU4, or pBGO- 
ATG-POU6 were prepared by PCR amplification from plasmids con- 
taining the corresponding cDNAs, pBGO-ATG-POU1 contains amino 
acids 296-455 of the Oct-1 protein (Sturm et al., 1988), pBGO-ATG- 
POU2 contains amino acids 193-355 of the Oct-2a protein (MLiller et 
al., 1988), pBGO-ATG-POU4 contains amino acids 98-254 of the Oct-4 
protein (SchSler et al., 1990), and pBGO-ATG-POU6 contains amino 
acids 238-395 of the Oct-6 protein (Suzuki et al., 1990). 
EMSA reactions were performed at room temperature with 10 fmol 
of a 32P-labeled 50 bp Sail DNA fragment containing the octamer site 
from the intron IgH enhancer. The binding buffer contained 50 mM 
KCI, 20 mM HEPES (pH 7.7), 1 mM EDTA, 0.25 mg/ml BSA, and 4% 
Ficol1400. Reactions with nuclear extracts contained 5-7 p.g of nuclear 
proteins, 2 p.g of poly(dl-dC), and 0.4 lig of denatured salmon sperm 
DNA. Reactions with reticulocyte lysates contained a total of 2 p.I of 
reticulocyte lysate, 0.4 p.g of poly(dl-dC), and 0.1 p.g of denatured 
salmon sperm DNA. When used, 1 p.I of the rnonoclonal antibody 
12CA5 (BAbCo) was added (at 1:50 dilution); in some reactions, 3 lig 
of the HA peptide was added as well. Gels were prerun for 2 hr and 
run for 2.5 hr at 200 V. 
Mammalian Expression and Luciferase Assays 
For expression in mammalian cells, the OBF-1 cDNA (clone 9) was 
inserted into the CMV-based expression vector pEVRF0 (Matthias et 
al., 1989) to create pEV-OBF-1, pEV-HA-OBF-1 was made by inserting 
an oligonucleotide ncoding the HA epitope at the 5' end of the OBF-1 
cDNA present in pEV-OBF-1. 
The reporter plasmids pKappaLucE, pKappaO-LucE, and pKap- 
paSP1LucE were made by inserting the 200 bp K promoter fragment 
from the corresponding NK-globin plasmid (Junker et al., 1990) into 
the pGL2 enhancer plasmid. The pH2BLucE plasmid was made simi- 
larly by cloning a 325 bp PCR fragment containing the human H2B 
histone gene promoter (positions -295 to +31). 
Cells were transfected by calcium-phosphate coprecipitation using 
3 p.g of reporter plasmid and varying amounts of expression vector 
DNA (from 0.5 to 5 lig); in each sample, the total amount of expression 
vector DNA (5 p,g) was kept constant by the addition of pEVRF0 DNA, 
and the total amount of DNA was brought to 20 I~g with salmon sperm 
DNA. Luciferase extracts were prepared 48-60 hr after transfection 
(Ausubel et al,, 1990), and equivalent protein amounts (100 p.g) were 
used for luciferase assays. 
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